
|Articles|July 1, 2017
- Pharmaceutical Executive-07-01-2017
- Volume 37
- Issue 7
Pharmaceutical Executive, July 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Building a Digital Health Infrastructurealmost 9 years ago
Patient Insights in the Age of AIalmost 9 years ago
Pharma Raises Stakes in Digital Healthalmost 9 years ago
Removing Uncertainty from the Drug Insurance Conversationalmost 9 years ago
Reflections from DIAalmost 9 years ago
Can AI Improve Sales Productivity in Pharma?almost 9 years ago
Improving Patients’ Lives and Boosting Mature Product Portfoliosalmost 9 years ago
Reinventing the Role of Medical Affairsalmost 9 years ago
Beyond KOL Marketing: Tapping Digital Opinion Influencersalmost 9 years ago
There’s a Digital Health App for That!Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




